HIMAngel

HIMAngel is an active angel and seed fund founded by Khaled Ismail, addressing the persistent early-stage funding gap for Egyptian healthcare startups. Stage focus is pre-seed and seed with checks in the $250k to $1M range, and AI is not flagged as a primary focus. The fund’s value proposition is operator-led: Ismail’s track record across Egyptian and MENA technology and his network within the Cairo healthcare ecosystem create real downstream advantages for portfolio companies that go beyond the check itself. The right founder for HIMAngel is an Egyptian or Egyptian-diaspora operator building a digital health, telehealth, healthcare software, or pharmacy-adjacent commerce business with credible Egyptian-market wedge and realistic regional expansion logic into Saudi Arabia, the UAE, or wider MENA. The wrong founder is a deep medtech or therapeutics team, a non-Egyptian founder using Cairo only as an engineering hub, or a Series A-ready company looking for an institutional lead. Intro paths run through Cairo’s tightly networked tech community including Flat6Labs Cairo alumni, the AUC and GUC operator networks, and the broader CDG-affiliated and World Bank-affiliated funder ecosystem operating in Egypt. Frequent co-investors and follow-on partners include Acasia Group (formerly Cairo Angels), 500 Sanabil MENA, Algebra Ventures, and Sawari Ventures. Direct outreach to Khaled Ismail is read and not unreasonable for credentialed founders, but warm intros from existing portfolio CEOs accelerate the process meaningfully. In the pitch, lead with the founding team’s depth in the Egyptian health system, the unit economics in EGP with realistic FX devaluation assumptions given the Egyptian pound’s recent volatility, and a credible regional expansion story. Be specific about Ministry of Health and Population posture, EDA pathways for any pharma or device exposure, and the rapidly evolving Personal Data Protection Law 151. Show that you understand the gap between Cairo and Alexandria’s middle-class consumer markets and the much larger but lower-ARPU rest of Egypt. Caveats include the structural FX volatility that has reshaped Egyptian startup unit economics in 2023-2025, the limited downstream Series A syndicate beyond a handful of MENA funds, and the reality that HIMAngel’s check alone will not finance a full seed round in most cases. Founders should plan parallel syndicate construction. For Egyptian healthcare entrepreneurs, HIMAngel is one of the most credible early partners with genuine ecosystem depth.